MoneyWorks4Me

Morepen Laboratories - Quaterly Results

12 Aug 2024 Evaluate
The quarter ended June 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 3856.43 millions.The Net Profit of the company reported a remarkable increase of 121.15% to Rs. 350.50  millions  from Rs. 158.49 millions in previous same quarter.Operating Profit saw a handsome growth to 516.82 millions from 268.87 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 3856.43 3691.03 4.48 3856.43 3691.03 4.48 15375.94 13388.83 14.84
Other Income 30.72 20.84 47.41 30.72 20.84 47.41 125.66 57.59 118.20
PBIDT 516.82 268.87 92.22 516.82 268.87 92.22 1743.84 830.29 110.03
Interest 10.44 2.83 268.90 10.44 2.83 268.90 35.09 19.81 77.13
PBDT 506.38 266.04 90.34 506.38 266.04 90.34 1708.75 810.48 110.83
Depreciation 35.90 48.93 -26.63 35.90 48.93 -26.63 219.00 180.06 21.63
PBT 470.48 217.11 116.70 470.48 217.11 116.70 1489.75 630.42 136.31
TAX 119.98 58.62 104.67 119.98 58.62 104.67 380.40 167.99 126.44
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.36 2.03 -314.78
PAT 350.50 158.49 121.15 350.50 158.49 121.15 1109.35 462.43 139.90
Equity 1022.27 1022.27 0.00 1022.27 1022.27 0.00 1022.27 1022.27 0.00
PBIDTM(%) 13.40 7.28 83.98 13.40 7.28 83.98 11.34 6.20 82.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..